140 filings
Page 6 of 7
8-K
v6m8wwbsy ae0j
24 Jul 13
CelatorĀ® Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
12:00am
424B3
is7ko 5sg
24 Jul 13
Prospectus supplement
12:00am
424B3
c9821
13 Jun 13
Prospectus supplement
12:00am
EFFECT
2yph e8gqlnsuw3s
10 Jun 13
Notice of effectiveness
12:00am
8-K
o2kqlx d1sogi
6 Jun 13
Departure of Directors or Certain Officers
12:00am
S-1
v7otz
31 May 13
IPO registration
12:00am
8-K
vezg66n4yd3phw9iwh
24 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
415ju67 7nz4m2emx
16 May 13
CelatorĀ® Pharmaceuticals Announces Business Update and Fiscal First Quarter 2013 Operational and Financial Results
12:00am
10-Q
jko 5zow1
15 May 13
Quarterly report
12:00am
D/A
d9h6z q52y7geptdntw
13 May 13
$39.26M in equity / options / securities to be acquired, sold $39.26M, 306 investors
12:00am
8-K
8oxt3l5cuqmuifu
3 May 13
Entry into a Material Definitive Agreement
12:00am
DEF 14C
3vq09zk2mxq ibu3bsy
30 Apr 13
Information statement
12:00am
PRE 14C
qc3ib2s7x6l4qrgle8t
19 Apr 13
Preliminary information
12:00am
8-K
v2c0e1ut1heu
18 Apr 13
Amendments to Articles of Incorporation or Bylaws
12:00am
10-K
r1yevsc8e0onw9r5re4
1 Apr 13
Annual report
12:00am
UPLOAD
zq8 7pd52zzn
29 Mar 13
Letter from SEC
12:00am
CORRESP
otcehc
19 Mar 13
Correspondence with SEC
12:00am
10-12G/A
iflcc1d7ua6k
19 Mar 13
Registration of securities (amended)
12:00am
8-K
dal 9dzvued
6 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
2ooq 658vu4ssf
12 Feb 13
Other Events
12:00am